4.8 Article

Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease

Related references

Note: Only part of the references are listed.
Review Hematology

Factor IXa inhibitors as novel anticoagulants

Emily L. Howard et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Article Medicine, General & Internal

Bivalirudin for patients with acute coronary syndromes

Gregg W. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Hematology

Monitoring unfractionated heparin with the aPTT: Time for a fresh look

John W. Eikelboom et al.

THROMBOSIS AND HAEMOSTASIS (2006)

Article Cardiac & Cardiovascular Systems

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes

John W. Eikelboom et al.

CIRCULATION (2006)

Article Medicine, General & Internal

Recombinant activated factor VII for acute intracerebral hemorrhage

SA Mayer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Critical Care Medicine

Antithrombotic therapy for coronary artery disease

RA Harrington et al.

CHEST (2004)

Review Critical Care Medicine

Coagulation disorders of cardiopulmonary bypass: a review

D Paparella et al.

INTENSIVE CARE MEDICINE (2004)

Article Cardiac & Cardiovascular Systems

Predictors of major bleeding in acute coronary syndromes:: the Global Registry of Acute Coronary Events (GRACE)

M Moscucci et al.

EUROPEAN HEART JOURNAL (2003)

Article Public, Environmental & Occupational Health

Hemorrhage after coronary artery bypass graft procedures

LA Herwaldt et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)

Article Multidisciplinary Sciences

RNA aptamers as reversible antagonists of coagulation factor IXa

CP Rusconi et al.

NATURE (2002)